Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
Below are our Buys for Tuesday, 24 August, as follows:
ACV Auctions Inc. (NASDAQ:ACVA): Citigroup upgraded the stock to Buy from Neutral but dropped the target price to 23 from 29. The consensus target is 36.
Bilbili Inc. (NASDAQ:BILI): Goldman reiterated a Buy rating and cut its price target to 105 from $122. Shares traded in a 52-wk range of 40.40 – 157.66.
Candel Therapeutics Inc. (NASDAQ:CADL): UBS initiated coverage with a Buy rating and a 9 price target. Credit Suisse started it with an Outperform rating and a 15 price target, and Jefferies started it with a Buy rating and a 22 price target.
MaxCyte Inc. (NASDAQ:MXCT): Stifel initiated coverage with a Buy rating and an 18 price target. BTIG started it with a Buy rating and a 22 price target. The stock trades in a 52-wk range of 13.77 – 17.44.
Rallybio Corp. (NASDAQ:RLYB): Jefferies started coverage with a Buy rating and a 20 price target. Since the IPO, the shares have traded between 11.86 – 25.78
Have a prosperous day, Keep the Faith!